Thank you! Your request has been received.
A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+
Knolens unifies scientific, regulatory, and clinical data into real-time, traceable intelligence—empowering confident decisions across Clinical, HEOR, and Market Access teams.
Knolens models access decisions with evolving data, monitors HTA and reimbursement in real time, and accelerates submissions with confidence. Strengthen payer narratives through scenarios and evidence.
Knolens facilitates better trial design through scenario modeling of key elements like inclusion criteria and endpoints, informed by past study data. This allows for instant feasibility assessment and optimization, ensuring alignment from design to execution with real-time insights.
Knolens provides scenario-based insights to anticipate regulatory reactions by simulating label changes, approval pathways, and clinical endpoint shifts. It enables tracking endpoint precedents and offers AI-curated, traceable evidence linked to policy for faster responses
Knolens empowers CI teams to simulate market shifts, track pipeline dynamics, and benchmark decisions by running what-if scenarios and anticipating competitive moves. Spot early signals and understand downstream impact.
Knolens enables smarter clinical development by simulating design, regulatory, and market strategies with real-world data. It helps monitor endpoint decisions, derisk go/no-go decisions, and align early development with market needs
Knolens models business scenarios in real time by integrating internal and public data, enabling users to understand the impact of external changes and supporting strategic planning with defensible AI insights.
Knolens empowers cross-functional teams across Clinical, HEOR, Market Access and more to execute real-time, traceable analyses—modeling endpoints, comparing study designs, and running scenario-based simulations using continuously updated, regulatory-grade data that is 100% traceable.
